Home › Metastatic Cancer › Washington

Pag-aaral pangklinika para sa Metastatic Cancer sa Washington

47 pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa mga site sa Washington.

Mga Lungsod sa Washington

Opisyal na teksto ng pag-aaral (English)

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Fred Hutchinson Cancer Center, Seattle

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06943755

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Cancer Institute-Issaquah, Issaquah
Providence Regional Cancer System-Lacey, Lacey
at 4 pa

Nagre-recruitPhase 2

Lahat ng edad · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05564377

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Northwest Medical Specialties, PLLC, Bonney Lake
Swedish Cancer Institute - Edmonds Campus, Edmonds
Swedish Medical Center - Edmonds, Edmonds
at 9 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07222800

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Swedish Cancer Institute, Seattle

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277413

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Virginia Mason Medical Center, Seattle
Fred Hutchinson Cancer Center, Seattle
University of Washington Medical Center, Seattle

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06989437

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Northwest Cancer Specialists, P.C., Vancouver

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07222566

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Tacoma

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Fred Hutchinson Cancer Center, Seattle

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07007559

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

University of Washington Fred Hutchinson Cancer Center, Seattle
Northwest Cancer Specialists, Vancouver

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07562152

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

University of Washington / Fred Hutchinson Cancer Center, Seattle

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT05118789

SLV-154 Treatment of Advanced Cancers

University of Washington / Fred Hutchinson Cancer Center, Seattle
Northwest Medical Specialties, PLLC, Tacoma

Nagre-recruitPhase 1

Edad 12 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06771219

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Swedish Cancer Institute - Edmonds, Edmonds
Providence Regional Cancer Partnership, Everett
UW Medicine Valley Medical Center, Renton
at 5 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07174336

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Swedish Cancer Institute - Edmonds, Edmonds
Swedish Medical Center, Seattle
Fred Hutchinson Cancer Center, Seattle

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213804

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Fred Hutchinson Cancer Center, Seattle
University Of Washington Medical Center, Seattle
Northwest Cancer Specialists, P.C., Vancouver

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07227415

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

Fred Hutchinson Cancer Center ( Site 0013), Seattle

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06863272

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of Washington, Fred Hutchinson Cancer Center, Seattle

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04585750

A Study of KK2269 in Adult Participants With Solid Tumors

University of Washington, Seattle

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06266299

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Fred Hutchinson Cancer Center, Seattle

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06625775

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Swedish Cancer Institute - Edmonds, Edmonds
Kadlec Clinic Hematology and Oncology, Kennewick
Swedish Medical Center, Seattle
at 2 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Seattle

Nagre-recruitPhase 1/2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07038343

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Cancer Care Northwest-1 (601 S. Sherman), Spokane
Cancer Care Northwest_2 (605 E. Holland), Spokane
Cancer Care Northwest, Spokane Valley

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06072612

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

Research Site, Puyallup

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07205822

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

Fred Hutchinson Cancer Research Center, Seattle

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT06803680

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Fred Hutch/University of Washington Cancer Consortium, Seattle

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04515810

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

Fred Hutchinson Cancer Center, Seattle
University of Washington Medical Center - Montlake, Seattle

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT05687110

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Research Site, Kennewick
Research Site, Seattle

Nagre-recruitPhase 3

Edad 18 pataas · Kababaihan · Na-update Hul 29, 2026 · NCT07044336

A Study of ASP1002 in Adults for Treatment of Solid Tumors

Swedish Cancer Institute, Edmonds

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT05719558

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT05098210

Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations

Fred Hutch/University of Washington Cancer Consortium, Seattle

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT06043713

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

MultiCare Regional Cancer Center, Auburn
MultiCare Regional Cancer Center, Gig Harbor
MultiCare Regional Cancer Center, Puyallup
at 2 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT06216301

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

VA Puget Sound Health Care System, Seattle

Nagre-recruitPhase 2

Edad 18 pataas · Kalalakihan · Na-update Hun 15, 2026 · NCT05422911

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Fred Hutchinson Cancer Center, Seattle

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT06917079

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Fred Hutchinson Cancer Center, Seattle

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT05384626

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Fred Hutchinson Cancer Center, Seattle

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT06757634

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Virginia Mason Medical Center, Seattle

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2026 · NCT05379985

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Virginia Mason Medical Center, Seattle

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT07020221

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

Fred Hutchinson Cancer Research Center, Seattle

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT06947928

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Fred Hutchinson Cancer Center, Seattle

Nagre-recruitPhase 2/3

Lahat ng edad · Lahat ng kasarian · Na-update Abr 2, 2026 · NCT06581406

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Northwest Medical Specialties, PLLC, Tacoma

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 1, 2026 · NCT05735080

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Fred Hutchinson Cancer Center, Seattle

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 25, 2026 · NCT06521554

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.